Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice.

http://www.ncbi.nlm.nih.gov/pubmed/16943435

A disintegrin and metalloprotease 33 (ADAM33) is a transmembrane protease and integrin ligand that has been identified as an asthma susceptibility gene product. To determine whether ADAM33 plays important roles in mammalian development and the modulation of allergic airway dysfunction, we generated ADAM33-null mice by gene targeting. ADAM33-null mice were born at expected Mendelian ratios, and both male and females developed normally and were fertile. No anatomical or histological abnormalities were detected in any tissues. In an animal model of allergic asthma, ADAM33-null mice showed normal allergen-induced airway hyperreactivity, immunoglobulin E production, mucus metaplasia, and airway inflammation. Our results demonstrate that ADAM33 is not essential for growth or reproduction in the mouse and does not modulate baseline or allergen-induced airway responsiveness.

Pubmed ID: 16943435 RIS Download

Mesh terms: ADAM Proteins | Allergens | Animals | Asthma | Breeding | Bronchial Hyperreactivity | Female | Gene Targeting | Growth and Development | Heterozygote | Immunoglobulin E | Inflammation | Lung | Male | Metaplasia | Mice | Mice, Knockout | Mucus | Phenotype

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: HL 53949
  • Agency: NHLBI NIH HHS, Id: HL 56385
  • Agency: NHLBI NIH HHS, Id: HL 64353
  • Agency: NHLBI NIH HHS, Id: HL 66600

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.